Danish Vulva Cancer Recurrence Study

Launched by UNIVERSITY OF AARHUS · Jul 3, 2024

Keywords

ClinConnect Summary

The Danish Vulva Cancer Recurrence Study, also known as DaVulvaRec, is a research project aimed at improving how we detect and manage the return of vulva cancer in women. This study will look at various ways to find out if the cancer has come back after treatment. Researchers will collect information directly from patients about their symptoms and experiences, as well as test blood samples to look for specific markers of the cancer. They hope to identify the best ways to monitor patients over a two-year period and improve treatment plans based on their findings.

To participate in this study, women must be at least 18 years old and have a confirmed diagnosis of vulva cancer. They should be able to understand information provided in Danish. Participants will be asked to fill out questionnaires every four months and provide blood samples for analysis. This study is recruiting women across Denmark and aims to include a total of 295 patients, while also comparing their experiences to a historical group of 1,000 other women diagnosed with vulva cancer in the past. Your involvement could help lead to better care and outcomes for future patients!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Primary or recurrent biopsy-verified squamous cell carcinoma of the vulva
• • ≥ 18 years of age
• • Able to understand oral and written information in Danish
• Exclusion Criteria:
• • Active treatment for concurrent cancer and/or dissemination of concurrent cancer